Development of imjSCORE for early prediction of response to nivolumab among patients with advanced cancer.

e14169Background: Cross-sectional Imaging (CI) plays an essential role in early assessment of patients on immune checkpoint inhibitors (ICIs), yet often remains inconclusive in the setting of advan...